UK-US Free Trade Deal Plans Disappoint Industry
UK Government Again Denies Claims That Drug Prices Will Rise
Executive Summary
The UK has published its negotiating mandate for talks on a free trade deal with the US. As expected, intellectual property protection figures prominently, but the life sciences industry sees little merit in the government’s approach. It also warns that the UK’s future relationship with the EU could lead to greater regulatory burdens and costs.